July 2010

6 July 2010

Indian regulator GEAC approves 17 Bt crops for trials

Even as the moratorium announced by Environment Ministry of India against Bt brinjal in February 2010 continues, the biotech regulator has approved field trials of 17 new genetically modified (GM) crops in the country, bringing smiles to the BioAgri industry and frown on the faces of anti-GM activists.

6 July 2010

FICCI, DOP to organize National Convention on Biopharma in India

Considering the fact that India is a significant player in the global biopharmaceutical industry, the Federation of Chamber of Commerce of India (FICCI) and the Department of Pharmaceuticals (DOP), Government of India, are all set to organize a one-day “National Convention on Biopharma” on July 12, 2010, at Federation House, New Delhi.

6 July 2010

Atorvastatin Beats Rosuvastatin in Protecting Kidneys in Diabetic and Nondiabetic Patients

July 2, 2010 (Munich, Germany) — Results of 2 related trials investigating the effects of statins on urinary protein excretion and kidney function found atorvastatin (ATV) protective and rosuvastatin (RSV) unprotective, and possibly harmful, in diabetic and nondiabetic patients.

6 July 2010

Study says normal adult blood can generate pluripotent stem cells

In findings likely to make it easier and faster for stem cell biologists to generate patient-specific embryonic-like stem cells, researchers at Children's Hospital Boston have reprogrammed adult blood cells into induced pluripotent stem (iPS) cells.

6 July 2010

NEWS: Intercell vaccine patch fails Phase II clinical trial

Intercell's investigational vaccine enhancement patch system for avian H5N1 influenza has failed a Phase II study. The company is working under a contract with Human and Health services (HHS) to develop a dose-sparing approach with potential for a single dose immunization combining a H5N1 vaccine with Intercell's LT adjuvant patch.

6 July 2010

Roches new DNA sequencer opens innovation in genomic research

Roche Diagnostics has announced the Asia Pacific launch of the GS Junior System, the company’s new next-generation DNA sequencing platform for life science research. The GS Junior System, developed by 454 Life Sciences, a Roche company, provides an integrated sequencing and bioinformatics solution, all in a size that is no bigger than a typical desktop laser printer.

5 July 2010

WINNERS OF ONLINE COMPETITION FAIR TEST-1

Yesterday, It was a great day in history of pharmatutor. The beginning of the Online Competition Fair was some what calm and major reason behind it, was server cracking because of inappropriate use by some users. Any how our engineers came back with solution and provided smooth user experience.